Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Bayer, Santen Aim to Lead Market with Simpler Eylea Administration
January 24, 2013
- Merck Serono Aims for Top 10 Slot in Oncology Field
January 23, 2013
- AZ Initiates First Multinational PI Study under Agreement with NCC
January 23, 2013
- DSP Establishes Subsidiary in Singapore Eyeing Development of Business Operations for Latuda in Asia
January 23, 2013
- Kobayashi Kako, Elmed Eisai Set to Launch Allegra Generics on February 1
January 23, 2013
- Sanofi’s Dellegra Promotion to Home in on Stuffy Nose
January 22, 2013
- Santen Obtains Approval for Preservative-Free Ophthalmic Solution Tapros
January 22, 2013
- Kyorin and Daiichi Sankyo to Cancel Agreement on Uritos in Brazil
January 22, 2013
- Pfizer Detailing Infectious Disease Portfolios across Divisions
January 21, 2013
- Tokyo District Court to Issue Ruling on Actos Patent Suit on Feb. 27 after Takeda Lost Legal Battle in Osaka
January 21, 2013
- Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development
January 21, 2013
- Daiichi Sankyo to Integrate Business Operations in Thailand with Ranbaxy
January 21, 2013
- Japan Could Get Left Behind in New Age of Open Innovation: Dr Fujimoto of Eli Lilly Japan
January 21, 2013
- Maruho to License Infantile Hemangioma Treatment from French Company
January 18, 2013
- Teijin Pharma Launches Acromegaly Treatment Somatuline
January 18, 2013
- Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013
January 18, 2013
- Ethical Drug Sales Up 2.4% in November: Crecon Report
January 18, 2013
- OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs
January 17, 2013
- AZ K.K. President Hudson to Leave, Operations in Japan under Control of UK CFO
January 17, 2013
- Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development
January 17, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…